33114490|t|Anti-Obesity Attributes; UHPLC-QTOF-MS/MS-Based Metabolite Profiling and Molecular Docking Insights of Taraxacum officinale.
33114490|a|The naturopathic treatment of obesity is a matter of keen interest to develop efficient natural pharmacological routes for disease management with low or negligible toxicity and side effects. For this purpose, optimized ultrasonicated hydroethanolic extracts of Taraxacum officinale were evaluated for antiobesity attributes. The 2,2-diphenyl-1-picrylhydrazyl method was adopted to evaluate antioxidant potential. Porcine pancreatic lipase inhibitory assay was conducted to assess the in vitro antiobesity property. Ultra-high performance chromatography equipped with a mass spectrometer was utilized to profile the secondary metabolites in the most potent extract. The 60% ethanolic extract exhibited highest extract yield (25.05 +- 0.07%), total phenolic contents (123.42 +- 0.007 mg GAE/g DE), total flavonoid contents (55.81 +- 0.004 RE/g DE), DPPH-radical-scavenging activity (IC50 = 81.05 +- 0.96 microg/mL) and pancreatic lipase inhibitory properties (IC50 = 146.49 +- 4.24 microg/mL). The targeted metabolite fingerprinting highlighted the presence of high-value secondary metabolites. Molecular-binding energies computed by docking tool revealed the possible contribution towards pancreatic lipase inhibitory properties of secondary metabolites including myricetin, isomangiferin, icariside B4, kaempferol and luteolin derivatives when compared to the standard drug orlistat. In vivo investigations revealed a positive impact on the lipid profile and obesity biomarkers of obese mice. The study presents Taraxacum officinale as a potent source of functional bioactive ingredients to impart new insights into the existing pool of knowledge of naturopathic approaches towards obesity management.
33114490	5	12	Obesity	Disease	MESH:D009765
33114490	103	123	Taraxacum officinale	Species	50225
33114490	155	162	obesity	Disease	MESH:D009765
33114490	290	298	toxicity	Disease	MESH:D064420
33114490	387	407	Taraxacum officinale	Species	50225
33114490	455	484	2,2-diphenyl-1-picrylhydrazyl	Chemical	MESH:C004931
33114490	539	546	Porcine	Species	
33114490	547	564	pancreatic lipase	Gene	69060
33114490	873	881	phenolic	Chemical	-
33114490	911	914	GAE	Chemical	-
33114490	928	937	flavonoid	Chemical	MESH:D005419
33114490	973	985	DPPH-radical	Chemical	-
33114490	1043	1060	pancreatic lipase	Gene	69060
33114490	1314	1331	pancreatic lipase	Gene	69060
33114490	1389	1398	myricetin	Chemical	MESH:C040015
33114490	1400	1413	isomangiferin	Chemical	MESH:C061492
33114490	1415	1427	icariside B4	Chemical	-
33114490	1429	1439	kaempferol	Chemical	MESH:C006552
33114490	1444	1452	luteolin	Chemical	MESH:D047311
33114490	1500	1508	orlistat	Chemical	MESH:D000077403
33114490	1567	1572	lipid	Chemical	MESH:D008055
33114490	1585	1592	obesity	Disease	MESH:D009765
33114490	1607	1612	obese	Disease	MESH:D009765
33114490	1613	1617	mice	Species	10090
33114490	1638	1658	Taraxacum officinale	Species	50225
33114490	1808	1815	obesity	Disease	MESH:D009765
33114490	Negative_Correlation	MESH:D047311	69060
33114490	Association	MESH:D008055	MESH:D009765
33114490	Negative_Correlation	MESH:C061492	69060
33114490	Negative_Correlation	MESH:D000077403	MESH:D047311
33114490	Negative_Correlation	MESH:C040015	69060
33114490	Negative_Correlation	MESH:D000077403	69060
33114490	Negative_Correlation	MESH:C006552	69060

